Apellis Pharmaceuticals
APLS
APLS
143 hedge funds and large institutions have $1.53B invested in Apellis Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.17% more ownership
Funds ownership: 68.69% → 75.86% (+7.2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
53% less call options, than puts
Call options by funds: $5.34M | Put options by funds: $11.4M
Holders
143
Holding in Top 10
4
Calls
$5.34M
Puts
$11.4M
Top Buyers
| 1 | +$162M | |
| 2 | +$41.9M | |
| 3 | +$40.2M | |
| 4 |
BlackRock
New York
|
+$28.4M |
| 5 |
Jennison Associates
New York
|
+$26.4M |
Top Sellers
| 1 | -$26M | |
| 2 | -$24.5M | |
| 3 | -$18M | |
| 4 |
VP
venBio Partners
San Francisco,
California
|
-$13.4M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$12.1M |